Dr PBN Prasad To Hold Charge As DCGI On Temporary Basis

New Delhi  (ANI): Dr PBN Prasad will hold the charge of the post of Drugs Controller General of India from February 16 to 28 this year or until further orders, an official notice said on Wednesday.

According to the official notice issued by Dr Kiran Kumar Karlapu, Deputy Secretary to the Government of India, “It has been decided with the approval of the Competent Authority, that Dr PBN Prasad, JDC(I) shall hold the charge of the post of Drug Controller of (India) under FR 49(v)wef 16.02.2023 till 28.02.2023 (date of his superannuation) or until further orders, whichever is earlier.”

Recently, UPSC recommended the name of Dr Rajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).

The Union Public Service Commission (UPSC) conducted interviews for the appointment of the DCGI last week. The top contenders were Dr VG Somani, Dr Rajeev Singh Raghuvanshi and Dr Jai Prakash. According to the sources soon final name will be announced.

Earlier in November last year, Dr V G Somani’s term as Drugs controller general of India (DCGI) was extended for three months that came into effect from November 16 last year. This was done the second time, however, earlier he got an extension in the month of August 22.

Dr Kiran Kumar Karlapu, Deputy Secretary, Department of Health and Family Welfare issued the circular regarding the extension of DCGI for a further period of three months.

Dr V G Somani was appointed as Drugs Controller General of India in the month of August 2019, DCGI heads the Central Drugs Standard Control Organisation (CDSCO) which is responsible for ensuring quality drug supply across the country. It also has the authority to give approval to new drugs and regulate clinical trials. (ANI)

  • Related Posts

    Pharma exporters raise red flag over JNCH customs delays at Nhava Sheva Port

    To address these concerns, a high-level team of Pharmexcil will meet the Commissioner, JNCH on July 7, 2026 Pharmaceutical exporters and importers are grappling with delays and procedural bottlenecks in customs…

    Gujarat to have region specific anti-snake venom in a year

    Snake Research Institute hands over lyophilised venom of four major venomous snake species found in state to a Telangana-based anti-venom manufacturer Gujarat is expected to have the first batch of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma exporters raise red flag over JNCH customs delays at Nhava Sheva Port

    Pharma exporters raise red flag over JNCH customs delays at Nhava Sheva Port

    Gujarat to have region specific anti-snake venom in a year

    Gujarat to have region specific anti-snake venom in a year

    Physicians Forum of India all set to bat a 1000 in CME for Healthy India

    Physicians Forum of India all set to bat a 1000 in CME for Healthy India

    Baby dies in Haryana’s Hisar as family’s 15-hour search for ventilator fails

    Baby dies in Haryana’s Hisar as family’s 15-hour search for ventilator fails

    Doctor, nurse removed after 2 maternal deaths in Jodhpur

    Doctor, nurse removed after 2 maternal deaths in Jodhpur

    Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

    Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India